ACAAI: Peanut Patch Safely Builds Tolerance Over Three Years in Peanut-Allergic Toddlers
No anaphylaxis seen during year 3, with fewer severe and local application-site reactions also observed
ACG: Incidence of Alpha-Gal Syndrome Increasing
Increase seen across 69 U.S. health systems, from about 1.8 percent in 2013-2014 to 38.5 percent in 2021-2022
Dupilumab Reduces Mucus Plug Scores With Moderate-to-Severe Asthma
Dupilumab treatment also improved patients’ lung function
~1 Percent of U.S. Docs Sponsored for H-1B Visas in Fiscal Year 2024
Counties with highest poverty level and rural counties had higher percentage of H-1B-sponsored physicians
Women Have Higher Odds of Chronic Rhinosinusitis Without Nasal Polyps
In a possible age-dependent trend, female participants 60 years or older had lower chronic rhinosinusitis prevalence
Higher Oxidative Balance Score Linked to Increased Odds of Allergic Rhinitis
In fully adjusted models, each unit increase in total OBS linked to 2 percent higher odds of allergic rhinitis
Social Determinants of Health Independent Risk Factors for Asthma
5.5 percent increase seen in asthma risk per SDoH index unit in unadjusted models, which remained significant after adjustment
IgE-Mediated Food Allergy Rates Decreased After Early Peanut Introduction Guidelines
From preguidelines to the postguidelines period, cumulative incidence and risk significantly decreased for development of peanut or any IgE-FA
Delirium Risk Increased for Seniors Prescribed First-Generation Antihistamines
Odds of delirium up 41 percent for patients admitted to physicians in the highest versus lowest quartile of first-generation antihistamine prescribing
Inhaler-Related Emissions Increased 24 Percent From 2014 to 2024
87 percent of total emissions were accounted for by albuterol, budesonide-formoterol, fluticasone propionate inhalers
